Authorized purpose: BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.
Clinical role
Concurrent detection and localization aid during radiograph interpretation; the clinical user makes the primary diagnosis and patient-management decision.
Images and patients
X-ray/Radiography · Spine
Key limitation
Keep in mind: Not indicated below age 2. Pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are adult-only. Use is limited to the specified body parts and views; out-of-scope images can return NOT AVAILABLE. Results are concurrent decision support and do not replace clinical interpretation.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Spine Input: DICOM 2D radiographs in specified views for ankle, foot, knee, tibia/fibula, wrist, hand, elbow, forearm, humerus, shoulder, clavicle, pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine, subject to age-specific labeling.
Who uses it?Intended users: Clinicians authorized to diagnose fractures in primary care, emergency medicine, urgent care, specialty care such as orthopedics, and radiologists reviewing radiographs.
What does the software produce?Output: A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.
What is its most important limitation?Key limitation: Not indicated below age 2. Pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are adult-only. Use is limited to the specified body parts and views; out-of-scope images can return NOT AVAILABLE. Results are concurrent decision support and do not replace clinical interpretation.
Clinical takeaway. Clinical role: BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.
Evidence takeaway. Evidence from the reviewed source record: The exact submission adds pediatric indications using a 2,000-radiograph standalone study and references the unchanged algorithm's earlier 24-reader, 480-case adult MRMC study. Pediatric operating points and adult aided-reader endpoints are kept distinct.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.
Concurrent detection and localization aid during radiograph interpretation; the clinical user makes the primary diagnosis and patient-management decision.
A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.
Clinicians authorized to diagnose fractures in primary care, emergency medicine, urgent care, specialty care such as orthopedics, and radiologists reviewing radiographs.
Not indicated below age 2. Pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are adult-only. Use is limited to the specified body parts and views; out-of-scope images can return NOT AVAILABLE. Results are concurrent decision support and do not replace clinical interpretation.
The exact submission adds pediatric indications using a 2,000-radiograph standalone study and references the unchanged algorithm's earlier 24-reader, 480-case adult MRMC study. Pediatric operating points and adult aided-reader endpoints are kept distinct.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact submission adds pediatric indications using a 2,000-radiograph standalone study and references the unchanged algorithm's earlier 24-reader, 480-case adult MRMC study. Pediatric operating points and adult aided-reader endpoints are kept distinct.
Pediatric standalone: 90.9% at the high-sensitivity operating point and 79.2% at the high-specificity operating point; adult carried-forward MRMC aided sensitivity: 75.2%.
Pediatric standalone: 82.1% at the high-sensitivity operating point and 96.5% at the high-specificity operating point; adult carried-forward MRMC aided specificity: 95.6%.
DesignStandalone fracture-detection performance comparison between pediatric and adult datasets at prespecified high-sensitivity and high-specificity operating points.
Population2,000 radiographs from patients aged 2-21 years, balanced between fracture-positive and fracture-negative examinations and spanning the pediatric-labeled anatomy and eight manufacturers.
Scopeexact submission
Tested versionBoneView 1.1-US configuration described in K222176
Samplen=2000
IndependenceSponsor or vendor study
K222176
The packet states the pediatric dataset was separate from training, tuning, and operating-point data. Dataset separation does not establish independent investigators.
BoneView adult MRMC study carried forward in K222176
DesignFully crossed retrospective multiple-reader, multiple-case study with aided and unaided sessions separated by at least one month.
Population480 adult cases interpreted by 24 clinical readers, with a three-US-board-certified-radiologist reference standard and multiple manufacturers.
Scopeexact submission
Tested versionUnchanged BoneView algorithm carried forward in K222176 from K212365
Samplen=480
IndependenceSponsor or vendor study
K222176 · K212365
The K222176 summary says no new clinical study was conducted and carries this predicate study forward because the algorithm was unchanged.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-submission FDA recall query returned no native recall record for K222176. This limited query does not establish absence of recalls or other safety information.
NICE HTG739 conditionally recommends BoneView for NHS use during a two-year evidence-generation period, subject to evidence-generation agreements and appropriate regulatory and DTAC approval; this is not a reimbursement determination.
NICE guidance for the NHS in England · England · Effective 2025-01-14
NICE's exploratory model uses GBP 1 per scan and states actual software, implementation, and postmarket costs are uncertain. Treat that figure as a health-technology-model assumption, not a vendor quote.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM 2D radiographs in specified views for ankle, foot, knee, tibia/fibula, wrist, hand, elbow, forearm, humerus, shoulder, clavicle, pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine, subject to age-specific labeling.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: BoneView receives studies from a DICOM source through an intermediate DICOM node and returns result files to a DICOM destination such as PACS or radiological equipment for viewing or onward transfer. Source and destination can differ.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: On-premise or cloud deployment connected to computing platforms, X-ray systems, or PACS, as described in the exact FDA comparison table.
Scope: Exact FDA submission. Current hosting region, retention, availability, and contracted topology still require site-specific confirmation.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
BoneView receives studies from a DICOM source through an intermediate DICOM node and returns result files to a DICOM destination such as PACS or radiological equipment for viewing or onward transfer. Source and destination can differ.
The exact FDA comparison table labels the device HIPAA compliant; it does not disclose the control scope, audit period, encryption, access-control, vulnerability-management, or incident-response evidence needed for procurement review.
Monitor age and body-part eligibility, supported-view routing, NOT AVAILABLE results, bounding-box operating point, DICOM delivery, disagreements and overrides, false negatives and false positives, downstream imaging/referrals, downtime, updates, complaints, and exact-submission recalls.
Exact FDA submission
Checked 2026-09-08
Buyer acceptance guidance derived from FDA labeling and NICE evidence gaps; it is not a claimed vendor monitoring service.
The exact packet describes automatic receipt through an intermediate DICOM node and return of summary/result images to a potentially different DICOM destination for PACS or equipment viewing.
Gleamer's current US BoneView page describes automatic second reading of trauma X-rays integrated into the reading workflow for adults and children over age 2. Current family claims are not used to broaden the exact K222176 body-part, view, or age labeling.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-08Last searched
26Fields reviewed
12Source classes checked
20Screened PubMed leads
6Screened trial leads
0Unreviewed FDA recall leads
Stored PubMed and trial candidates were screened by identifier and metadata only. None was promoted without full-text or registry-record review; this is not a systematic evidence review. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, health technology guidance, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-08 - Exact FDA submission
NICE's GBP 1-per-scan figure is an exploratory model assumption, not a BoneView quote or public list price.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
NICE HTG739 is conditional English NHS adoption guidance, not a payer coverage or product-specific reimbursement determination.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-version onboarding, role-based training, competency checks, support response, and retraining after updates were not established.
AutoDensity estimates L1-L4 spine bone-mineral density from EOSedge dual-energy AP radiographs for opportunistic orthopedic pre-surgical assessment; it is not a replacement for DXA confirmation.
Authorized purpose: BoneMetrics is fully automated software that assists trained radiology professionals with Cobb-angle measurement on frontal spine radiographs in patients aged four years or older with suspected or present spinal deformity or scoliosis; it is not a replacement for complete evaluation or sole diagnosis.
Authorized purpose: Automated analysis of sagittal lumbar and cervical spine radiographs to produce static and motion metrics supporting qualified practitioners' decision-making in skeletally mature patients age 18 and above.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.